Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Clinical Evaluation of the Efficacy and Tolerability of AnteAGE Biosomes and Facial Radiofrequency Microneedling

Authors not listed

Cellese Inc. · 2024

Abstract

This prospective, randomized controlled study evaluated the efficacy and tolerability of AnteAGE Biosome Solution used in conjunction with facial radiofrequency microneedling. Eligible participants with facial rhytids and/or uneven skin tone and texture were randomized 1:1 to an active treatment group or a control group. All participants underwent facial radiofrequency microneedling. Participants in the active group received AnteAGE Biosome Solution during treatment and an AnteAGE skincare regimen, while control participants received hyaluronic acid as the treatment glide and control skincare products. Clinical outcomes included standardized facial photography, investigator assessments, Global Aesthetic Improvement Scale assessments, participant-reported outcomes, and assessment of adverse reactions and post-procedure healing through Day 60.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-27 MST

Cite this

APA
Anonymous. (2024). Clinical Evaluation of the Efficacy and Tolerability of AnteAGE Biosomes and Facial Radiofrequency Microneedling. <em>Cellese Inc.</em>. https://clinicaltrials.gov/study/NCT07849556
Vancouver
Anonymous. Clinical Evaluation of the Efficacy and Tolerability of AnteAGE Biosomes and Facial Radiofrequency Microneedling. Cellese Inc.. 2024.
BibTeX
@misc{anon2024Clinic, title = {Clinical Evaluation of the Efficacy and Tolerability of AnteAGE Biosomes and Facial Radiofrequency Microneedling}, author = {Anonymous}, journal = {Cellese Inc.}, year = {2024}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings